Conte Andrea, Pierantoni Giovanna Maria
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli "Federico II", 80131, Naples, Italy.
Microrna. 2015;4(3):148-57. doi: 10.2174/2211536604666151002002720.
The homeodomain-interacting protein kinase (HIPK) family consists of four evolutionarily conserved and highly related nuclear serine/threonine kinases of recent discovery. They interact with homeobox proteins and other transcription factors, as well as transcriptional coactivators or corepressors depending on the cellular context. HIPK proteins are sensors for various extracellular stimuli, which control key cellular functions such as signal transduction to downstream effectors that regulate apoptosis, embryonic development, DNA-damage response, and cellular proliferation. Thus, HIPKs are involved in proliferative diseases such as cancer and fibrosis. mRNA levels and protein stability tightly regulate expression levels of HIPKs.
Here, we review recent works investigating the regulation of HIPKs expression by microRNAs (miRNAs) that are involved in the control of cell proliferation, sensitivity to chemotherapeutic drugs, epithelial-mesenchymal transition, and glucose-stimulated insulin secretion.
It appears that HIPK family members, and their related miRNAs, may be considered as novel therapeutic targets for treating cancer, renal fibrosis and type 2 diabetes.
同源结构域相互作用蛋白激酶(HIPK)家族由最近发现的四种进化保守且高度相关的核丝氨酸/苏氨酸激酶组成。它们与同源框蛋白和其他转录因子相互作用,以及根据细胞环境与转录共激活因子或共抑制因子相互作用。HIPK蛋白是各种细胞外刺激的传感器,其控制关键的细胞功能,如向调节细胞凋亡、胚胎发育、DNA损伤反应和细胞增殖的下游效应器的信号转导。因此,HIPK参与诸如癌症和纤维化等增殖性疾病。mRNA水平和蛋白质稳定性紧密调节HIPK的表达水平。
在此,我们综述了最近研究微小RNA(miRNA)对HIPK表达调控的工作,这些miRNA参与细胞增殖控制、对化疗药物的敏感性、上皮-间质转化和葡萄糖刺激的胰岛素分泌。
似乎HIPK家族成员及其相关的miRNA可被视为治疗癌症、肾纤维化和2型糖尿病的新型治疗靶点。